Mark D Griffiths Selected Research

COVID-19

11/2022	Associations between vaccination and quality of life among Taiwan general population: A comparison between COVID-19 vaccines and flu vaccines.
1/2022	Cyberchondria, Fear of COVID-19, and Risk Perception Mediate the Association between Problematic Social Media Use and Intention to Get a COVID-19 Vaccine.
1/2022	The Fear of COVID-19 Scale: Development and Initial Validation.
1/2022	The Motors of COVID-19 Vaccination Acceptance Scale (MoVac-COVID19S): Measurement Invariant Evidence for Its Nine-Item Version in Taiwan, Indonesia, and Malaysia.
12/2021	A population-based dataset concerning predictors of willingness to get a COVID-19 vaccine in Iran.
11/2021	Factors affecting Pakistani young adults' intentions to uptake COVID-19 vaccination: An extension of the theory of planned behavior.
10/2021	Extended theory of planned behavior in explaining the intention to COVID-19 vaccination uptake among mainland Chinese university students: an online survey study.
6/2021	Fear of COVID-19 and Perceived COVID-19 Infectability Supplement Theory of Planned Behavior to Explain Iranians' Intention to Get COVID-19 Vaccinated.
3/2021	Measurement Invariance of the Drivers of COVID-19 Vaccination Acceptance Scale: Comparison between Taiwanese and Mainland Chinese-Speaking Populations.
3/2021	Depression and anxiety symptoms associated with internet gaming disorder before and during the COVID-19 pandemic: A longitudinal study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark D Griffiths Research Topics

Disease

13	COVID-19 11/2022 - 10/2020
5	Gambling (Pathological Gambling) 06/2022 - 09/2015
4	Substance-Related Disorders (Drug Abuse) 04/2022 - 06/2018
2	Infections 01/2021 - 10/2020
2	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2020 - 01/2020
2	Mental Disorders (Mental Disorder) 01/2020 - 01/2018
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 11/2017 - 06/2013
1	Specific Phobia 01/2022
1	Overweight 12/2021
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Human Influenza (Influenza) 10/2021
1	Feeding and Eating Disorders (Eating Disorder) 06/2021
1	Bulimia (Binge Eating) 06/2021
1	Schizophrenia (Dementia Praecox) 11/2020
1	Atrophy 01/2020
1	Heart Failure 01/2020
1	Alcoholism (Alcohol Abuse) 01/2019
1	Warts (Wart) 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Death (Near-Death Experience) 01/2018
1	Confusion (Bewilderment) 06/2017
1	Fibromyalgia (Fibrositis) 02/2017
1	Compulsive Sexual Behavior Disorder 06/2016
1	Psychotic Disorders (Schizoaffective Disorder) 02/2014

Drug/Important Bio-Agent (IBA)

9	Immunoglobulin D (IgD)IBA 03/2021 - 06/2017
4	COVID-19 VaccinesIBA 11/2022 - 10/2021
3	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2022 - 01/2020
3	VaccinesIBA 11/2021 - 01/2021
3	Indicators and Reagents (Reagents)IBA 01/2019 - 09/2015
2	SuspensionsIBA 02/2021 - 10/2020
2	Pharmaceutical PreparationsIBA 01/2019 - 06/2018
2	Biological ProductsIBA 01/2018 - 12/2017
1	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2022
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 04/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2022
1	SolutionsIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	BESIBA 06/2021
1	Prostaglandins AIBA 06/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2019
1	Nicotine FDA Link 06/2018

Therapy/Procedure

4	Behavior Control 12/2021 - 06/2021
4	Meditation 01/2018 - 06/2013
2	Therapeutics 06/2022 - 02/2014
1	Self Medication 11/2020